Between Patients and Providers Virtual Edition

Modern Approach to the Treatment of Type 1 and Type 2 Diabetes

An Interactive Online Continuing Medical Education Conference Experience For MDs, CDCESs, RNs, and ALL YOU HEALTHCARE PROS!

Healthcare professionals who attend Making the Connection will…


•  LEARN from the nations LEADING experts in diabetes treatment

•  Get their questions answered in LIVE Q&A Discussion Panels


•  Network with Healthcare Professionals from AROUND THE WORLD

•  Most importantly, help THEIR PATIENTS reach their treatment goals


We focus on four distinct areas of the most cutting-edge diabetes management strategies:


  • Patient-provider relationships with a focus on communication methods to improve adherence and persistence
  • Oral agents for the treatment of type 2 diabetes and their effect on cardiovascular health
  • Injectable therapies, including insulin, for use in patients with type 2 diabetes and their cardiovascular impact
  • Time in range and the unmet needs of type 1 diabetes


Meet TCOYD’s Founder & Director

Dr. Steven V. Edelman is a Clinical Professor of Medicine at UCSD School of Medicine, the Director of the Diabetes Care Clinic at the VA Medical Center in San Diego and a type 1 since the age of 15. He’s dedicated his medical career to bringing diabetes education and cutting-edge management strategies directly to the people who need it most, people who have diabetes and the medical professionals who treat them.

“Thank you for continuing to provide this excellent educational event for health professionals who treat people with diabetes. This conference should be made mandatory for all primary care providers!”

– Santa Clara, CA Making the Connection Conference Participant

Making the Connection Planning Committee:


Steven V. Edelman, MD – Endocrinologist, Founder & Director, TCOYD; Clinical Professor of Medicine, UCSD School of Medicine; Director, Diabetes Care Clinic, VA Medical Center San Diego

Jeremy H. Pettus, MD – Endocrinologist, Type 1 Track Co-Director, TCOYD; Assistant Professor of Medicine, UCSD School of Medicine

William Polonsky, PhD, CDE – President, Behavioral Diabetes Institute; Associate Clinical Professor, Department of Psychiatry, University of California San Diego

Tricia Santos Cavaiola, MD – University of California, San Diego School of Medicine

Schafer Boeder, MD – University of California, San Diego School of Medicine



Stay tuned for more details!


Learning Objectives

At course completion, participants should be able to:

1. Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities. 7. Design a treatment plan for multiple daily injection regimens and insulin pump therapy.
2. Develop individualized treatment strategies based on the living standards of care and patient characteristics.8. Explain how to interpret continuous glucose monitoring (CGM) data.
3. Discuss the recently published cardiovascular-renal outcome trials on oral and injectable type 2 medications.9. Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation.
4. Summarize the most up-to-date clinical information on GLP-1 RA and SGLT-2 inhibitors.10. Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).
5. Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD).11. Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.
6. Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach.


This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Uni­versity of California, San Diego School of Medicine and Taking Control of Your Diabetes. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Cate­gory 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of re-licensure, the Califor­nia Board of Registered Nursing accepts AMA PRA Category 1 credits™ (report up to 6.0 hours of credit and list “CME Category 1” as the provider number).

Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Phy­sician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.

Certified Diabetes Educators: The University of California, San Diego is accredited by the ACCME, which is on the NCBDE list of approved providers.

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Credit Designation

Global Education Group designates this continuing education activity for 6.0 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education.  (Universal Activity Number – 0530-9999-20-092-L01-P) 


This is a knowledge based activity.


Attention HCPs from outside of the US: To see if you are eligible to receive CME credits check here.

Cultural and Linguistic Competency

This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources can be found on the UC San Diego CME website.

Acknowledgement of Commercial Support

This activity is supported by educational grants from:
Amarin Pharma Inc., AstraZeneca, Dexcom, Lilly USA, LLC,
Medtronic Diabetes, Merck Sharp & Dohme Corp, NovoNordisk, Inc., and Xeris Pharmaceuticals, Inc.

This activity is jointly provided by Taking Control Of Your Diabetes, UC San Diego School of Medicine, and Global Education Group.